Institutional investors control 0.33% of the outstanding shares in PBMD. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2015, these large investors purchased a net $147.2 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 67.3 Thousand shares of Prima BioMed Ltd
UBS SECURITIES LLC Bought 5.3 Thousand shares of Prima BioMed Ltd
KCG AMERICAS LLC Bought 4.8 Thousand shares of Prima BioMed Ltd